Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)

NCT01045798 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Low participant enrollment: 15 enrolled of 114 planned

Conditions

Invasive Candidiasis

Interventions

DRUG: Caspofungin acetate
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]